Oliver McDonald, assistant professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine, and a group of colleagues are responsible for this study in which they further assert that the finding would prevent the formation of tumors. To date, there has been no "evidence of other agents acting selectively on aggressive metastatic diseases" according to that expert.

A group of experts identified a component that could reverse the reprogramming of pancreatic cancer with metastases, according to a study released Monday in Nature Genetics. According to research by experts at the Vanderbilt Cancer Center, it may be possible to reverse the reprogramming of cancer malignancy to apply treatments to pancreatic cancer that has spread to other organs. More information.